Sarcomatoid mesothelioma and its histological mimics: A comparative immunohistochemical study

Histopathology

Volumn 42, Issue 3, 2003, Pages 270-279

  Lucas, David R ^a,b   Pass, H I ^a   Madan, S K ^a   Adsay, N V ^a   Wali, A ^a   Tabaczka, P ^a   Lonardo, F ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Immunohistochemistry; Mesothelioma; Neoplasms of pleura and lung; Sarcoma; Sarcomatoid carcinoma

Indexed keywords

ALPHA ACTIN; CALRETININ; CYTOKERATIN; EPITOPE; THROMBOMODULIN; THYROID TRANSCRIPTION FACTOR 1; WT1 PROTEIN;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; FIBROSARCOMA; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEIOMYOSARCOMA; LUNG BIOPSY; LUNG SARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MICROSCOPY; OSTEOSARCOMA; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMATOID MESOTHELIOMA; SPINDLE CELL CARCINOMA; SYNOVIAL SARCOMA;

CARCINOSARCOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MESOTHELIOMA; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0037343541     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01583.x     Document Type: Article

References (26)

1. Carella R. DeLeonardi G. D'Errico A et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis. Am. J. Surg. Pathol. 2001: 25; 43-50.
2. Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG. Value of the mesothelioma-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44 in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Mod. Pathol. 2000: 13; 107-112.
3. Oates J, Edwards C, HBME-1. MOC-31. WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 2000; 36; 341-347.
4. Attanoos RL, Dojcinov SD, Webb R. Gibbs AR. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 2000; 37; 224-231.
5. Carter D, Otis CN. Three types of spindle cell tumors of the pleura. Fibroma, sarcoma, and sarcomatoid mesothelioma. Am. J. Surg. Pathol. 1988: 10; 747-753.
6. Doglioni C, Tos AP, Laurino L et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am. J. Surg. Pathol. 1996; 9; 1037-1046.
7. Kumar-Singh S, Segers K, Rodeck U et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J. Pathol. 1997: 181; 67-74.
8. Montag AG, Pinkus GS, Corson JM. Keratin protein immunoreactivity of sarcomatoid and mixed types of diffuse malignant mesothelioma. An immunoperoxidase study of 30 cases. Hum. Pathol. 1988: 19; 336-342.
9. Carbone M, Pass HI, Rizzo P et al. Simian virus 40-like sequences in human pleural mesothelioma. Oncogene 1994: 9; 1781-1790.
10. Kung IT, Thallus V, Spencer EJ, Wilson SM. Expression of muscle actins in diffuse mesotheliomas. Hum. Pathol. 1995; 26; 565-570.
11. Mayall FG. Goddard H. Gibbs AR. Intermediate filament expression in mesotheliomas: leiomyoid mesotheliomas are not uncommon. Histopathology 1992: 21; 453-457.
12. Andrion A, Mazzucco G, Bernardi P, Mollo F, Sarcomatous tumor of the chest wall with osteochondroid differentiation. Evidence of mesothelial origin. Am. J. Surg. Pathol. 1989: 13; 707-712.
13. Kiyozuka Y, Miyazaki H, Yoshizawa K et al. An autopsy case of malignant mesothelioma with osseous and cartilaginous differentiation: bone morphogenic protein-2 in mesothelial cells and its tumor. Dig. Dis. Sci. 1999: 44; 1626-1631.
14. Krishna J, Haqqani MT. Liposarcomatous differentiation in diffuse pleural mesothelioma. Thorax 1993; 48; 409-410.
15. Beasley MB, Fanburg-Smith JC, Fujii T. Travis WD. Calretinin staining in synovial sarcoma: a potential pitfall in pleural biopsy interpretation (Abstract). Mod. Pathol. 2001: 14; 217A.
16. Amin KM. Litzky LA. Smythe WR et al. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol. 1995: 146; 344-356.
17. Herman MA, Stotzer M, Lucas DR, Lucas CE. Urachal leiomyosarcoma: case report and review. J. Urologic Pathol. 2001: 13; 49-55.
18. Battifora H. McCaughey WTE. Tumors of the serous membranes. In: Atlas of tumor pathology, third series, fascicle 15. Washington DC: American Registry of Pathology, 1995; 17-88.
19. Bury T. Hermans G, Alexis-Agnant R, Chevalier P, Limet R, Bartsch P. Clear cell sarcoma: an extremely rare cause of pleural disease. Eur. Respir. J. 1997; 10: 2653-2656.
20. Falconieri G, Bussani R, Mirra M, Zanella M. Pseudomesotheliomatous angiosarcoma: a pleuropulmonary lesion simulating malignant pleural mesothelioma. Histopathology 1997; 30; 419-424.
21. Goetz SP. Robinson RA, Landas SK, Extraskeletal myxoid chondrosarcoma of the pleura: report of a case simulating mesothelioma. Am. J. Clin. Pathol. 1992; 97: 498-502.
22. Hamada T. Tanimoto A, Kaido M. Matsumoto S, Iribe K, Koide O. Diffuse pleural rhabdomyosarcoma with persistent pleural effusion. Acta Pathol. Jpn 1989; 39: 803-809.
23. Moran CA, Suster S, Koss MN. Smooth muscle tumours presenting as pleural neoplasms. Histopathology 1995: 27; 227-234.
24. Ordonez NG. Tornos C. Malignant peripheral nerve sheath tumor of the pleura with epithelial and rhabdomyoblastic differentiation: report of a case clinically simulating mesothelioma. Am. J. Surg. Pathol. 1997; 12; 1515-1521.
25. Crotty TB. Myers JL. Katzenstein AL, Tazelaar HD. Swensen SJ, Churg A. Localized malignant rhesothelioma. A clinicopathologic and flow cytometric study. Am. J. Surg. Pathol. 1994; 18; 357-363.
26. Yesner R, Hurwitz A. Localized pleural mesothelioma of epithelial type. J. Thorac. Surg. 1953; 26; 325-329.